China’s Healthcare Reforms May Prompt New Leadership To Examine Costs – State Council White Paper
This article was originally published in PharmAsia News
Executive Summary
China’s State Council has laid down a marker on the scope and pace of healthcare reforms by issuing a white paper that may prompt China’s new leadership to accelerate reforms aimed at controlling costs in the face of longer life expectancy and surging chronic disease cases.